Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024
Compare Balance Sheet Results of Aarey Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
28.45
6.44
22.01
341.77%
Share Warrants & Outstandings
Total Reserve
107.51
23.98
83.53
348.33%
Shareholder's Funds
138.48
30.42
108.06
355.23%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
1.99
3.85
-1.86
-48.31%
Secured Loans
1.99
0.72
1.27
176.39%
Unsecured Loans
0.00
3.13
-3.13
-100.00%
Deferred Tax Assets / Liabilities
0.92
0.03
0.89
2,966.67%
Other Long Term Liabilities
0.00
0.12
-0.12
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
2.91
2.77
0.14
5.05%
Current Liabilities
Trade Payables
102.54
0.97
101.57
10,471.13%
Other Current Liabilities
11.07
3.39
7.68
226.55%
Short Term Borrowings
32.87
2.44
30.43
1,247.13%
Short Term Provisions
2.73
0.00
2.73
0.00%
Total Current Liabilities
149.21
6.80
142.41
2,094.26%
Total Liabilities
290.59
39.98
250.61
626.84%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
39.10
2.80
36.30
1,296.43%
Less: Accumulated Depreciation
22.88
0.84
22.04
2,623.81%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
16.22
1.97
14.25
723.35%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.12
0.10
2.02
2,020.00%
Long Term Loans & Advances
6.64
0.03
6.61
22,033.33%
Other Non Current Assets
0.01
1.46
-1.45
-99.32%
Total Non-Current Assets
24.98
3.56
21.42
601.69%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
45.48
17.38
28.10
161.68%
Sundry Debtors
133.46
9.58
123.88
1,293.11%
Cash and Bank
1.47
0.85
0.62
72.94%
Other Current Assets
0.78
0.88
-0.10
-11.36%
Short Term Loans and Advances
84.41
7.73
76.68
991.98%
Total Current Assets
265.61
36.42
229.19
629.30%
Net Current Assets (Including Current Investments)
116.40
29.62
86.78
292.98%
Total Current Assets Excluding Current Investments
265.61
36.42
229.19
629.30%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
290.59
39.98
250.61
626.84%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
34.86
3.80
31.06
817.37%
Book Value per share (adjusted)
46.90
47.26
-0.36
-0.76%
Annual - Borrowings
Borrowings 34.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 16.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Annual - Investments
Investments 2.12 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Annual - Current Assets
Current Assets 265.61 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024






